These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1374106)

  • 1. Expansion of murine T cells bearing a unique T cell receptor beta-chain in Friend virus-induced tumor in situ.
    Suzuki M; Koseki H; Mizutani Y; Kuribayashi K; Kanno M; Taniguchi M
    J Immunol; 1992 May; 148(9):2968-73. PubMed ID: 1374106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The T-cell receptor V beta gene usage in tumor-infiltrating lymphocytes and blood of patients with hepatocellular carcinoma.
    Weidmann E; Whiteside TL; Giorda R; Herberman RB; Trucco M
    Cancer Res; 1992 Nov; 52(21):5913-20. PubMed ID: 1382847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shared amino acid sequences in the ND beta N and N alpha regions of the T cell receptors of tumor-infiltrating lymphocytes within malignant glioma.
    Ebato M; Nitta T; Yagita H; Sato K; Okumura K
    Eur J Immunol; 1994 Dec; 24(12):2987-92. PubMed ID: 7805726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of both T cell receptor V alpha and V beta variable region domains and alpha chain junctional region in viral antigen recognition.
    Brändle D; Bürki K; Wallace VA; Rohrer UH; Mak TW; Malissen B; Hengartner H; Pircher H
    Eur J Immunol; 1991 Sep; 21(9):2195-202. PubMed ID: 1716213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biased T cell receptor usage by Ld-restricted, tum- peptide-specific cytotoxic T lymphocyte clones.
    Solheim JC; Alexander-Miller MA; Martinko JM; Connolly JM
    J Immunol; 1993 Feb; 150(3):800-11. PubMed ID: 8380825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for oligoclonal T-cell response in a metastasis of renal cell carcinoma responding to vaccination with autologous tumor cells and transfer of in vitro-sensitized vaccine-draining lymph node lymphocytes.
    Weidmann E; Logan TF; Yasumura S; Kirkwood JM; Trucco M; Whiteside TL
    Cancer Res; 1993 Oct; 53(20):4745-9. PubMed ID: 8402652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited T cell antigen receptor repertoire in tumor-infiltrating lymphocyte and inhibition of experimental lung metastasis of murine melanoma by anti-TCR antibody.
    Wang R; Taniguchi M
    J Immunol; 1995 Feb; 154(4):1797-803. PubMed ID: 7836764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rejection of an IA+ variant line of FBL-3 leukemia by cytotoxic T lymphocytes with CD4+ and CD4-CD8- T cell receptor-alpha beta phenotypes generated in CD8-depleted C57BL/6 mice.
    Yoshimura A; Shiku H; Nakayama E
    J Immunol; 1993 Jun; 150(11):4900-10. PubMed ID: 8496592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased frequency of 2,4,6-trinitrophenyl (TNP)-specific, H-2b-restricted cytotoxic T lymphocyte precursors in transgenic mice expressing a T cell receptor beta chain gene from an H-2b-restricted, TNP-specific cytolytic T cell clone.
    Iglesias A; Hansen-Hagge T; Von Bonin A; Weltzien HU
    Eur J Immunol; 1992 Feb; 22(2):335-41. PubMed ID: 1311259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of T cell receptor alpha beta variability in tumor-infiltrating lymphocytes in primary and metastatic melanoma.
    Zeuthen J; Birck A; Straten PT
    Arch Immunol Ther Exp (Warsz); 1995; 43(2):123-33. PubMed ID: 8744727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The T cell receptor gene usage by simian immunodeficiency virus gag-specific cytotoxic T lymphocytes in rhesus monkeys.
    Chen ZW; Shen L; Regan JD; Kou Z; Ghim SH; Letvin NL
    J Immunol; 1996 Feb; 156(4):1469-75. PubMed ID: 8568249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of T-cell receptor V region gene usage of cytotoxic T-lymphocytes and tumor-infiltrating lymphocytes derived from human autologous gastric signet ring cell carcinomas.
    Ikeda H; Sato N; Matsuura A; Kikuchi K
    Cancer Res; 1993 Jul; 53(13):3078-84. PubMed ID: 8391386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone.
    Sensi M; Salvi S; Castelli C; Maccalli C; Mazzocchi A; Mortarini R; Nicolini G; Herlyn M; Parmiani G; Anichini A
    J Exp Med; 1993 Oct; 178(4):1231-46. PubMed ID: 8376931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TCR alpha-chain usage can determine antigen-selected TCR beta-chain repertoire diversity.
    Turner SJ; Cose SC; Carbone FR
    J Immunol; 1996 Dec; 157(11):4979-85. PubMed ID: 8943404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conserved V(D)J junctional sequence of cross-reactive cytotoxic T cell receptor idiotype and the effect of a single amino acid substitution.
    Hirama T; Takeshita S; Matsubayashi Y; Iwashiro M; Masuda T; Kuribayashi K; Yoshida Y; Yamagishi H
    Eur J Immunol; 1991 Feb; 21(2):483-8. PubMed ID: 1705514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diversity and dominance among TCR recognizing HLA-A2.1+ influenza matrix peptide in human MHC class I transgenic mice.
    Man S; Ridge JP; Engelhard VH
    J Immunol; 1994 Nov; 153(10):4458-67. PubMed ID: 7963521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Junctional diversity in the absence of N regions. Neonatal T cell receptor beta chain junctional sequences are more heterogeneous than neonatal T cell receptor gamma delta or IgH junctions.
    Feeney AJ
    J Immunol; 1993 Sep; 151(6):3094-9. PubMed ID: 8397251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peri-islet infiltrates of young non-obese diabetic mice display restricted TCR beta-chain diversity.
    Galley KA; Danska JS
    J Immunol; 1995 Mar; 154(6):2969-82. PubMed ID: 7533189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Participation of a dominant cytotoxic T cell population defined by a monoclonal antibody in syngeneic anti-tumor responses.
    Matsubayashi Y; Hirama T; Morioka A; Iwashiro M; Masuda T; Uchino H; Takeshita S; Yamagishi H; Udono H; Mieno M
    Eur J Immunol; 1990 Sep; 20(9):2095-103. PubMed ID: 1698639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection for amino acid sequence and J beta element usage in the beta chain of DBA/2V beta b- and DBA/2V beta a-derived myoglobin-specific T cell clones.
    Ruberti G; Paragas V; Kim D; Fathman CG
    J Immunol; 1993 Dec; 151(11):6185-94. PubMed ID: 8245460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.